Pre-treatment | 1-year treatment | 1.5-year treatment | ||||
Patient | Normal | Patient | Normal | Patient | Normal | |
FEV1 (L) | 2.37 | 3.26 | 2.67 | 3.10 | 2.67 | 3.01 |
FVC (L) | 3.07 | 3.78 | 3.48 | 3.69 | 3.70 | 3.64 |
TLC (L) | 4.67 | 5.66 | 5.38 | 5.61 | 5.71 | 5.55 |
FEV1/FVC ratio (%) | 77.2 | Within 5% of the predicted ratio | 76.7 | Within 5% of the predicted ratio | 72.2 | Within 5% of the predicted ratio |
FEV1%pred (%) | 72.7 | 80–120 | 86.1 | 80–120 | 88.7 | 80–120 |
FVC%pred (%) | 81.2 | 80–120 | 94.3 | 80–120 | 101.6 | 80–120 |
TLC%pred (%) | 82.5 | 80–120 | 95.9 | 80–120 | 102.9 | 80–120 |
DLCO%pred (%) | 27.1 | 80–120 | 30.0 | 80–120 | 30.7 | 80–120 |
DLCO/VA ratio (mL/min/mm Hg/L) | 2.32 | 5.06 | 1.76 | 4.91 | 1.80 | 4.88 |
RV (L) | 1.55 | 1.54 | 2.03 | 1.6 | 1.93 | 1.58 |
DLCO%pred, percentage-predicted diffusing capacity of the lungs for carbon monoxide; FEV1, forced expiratory volume in 1 s; FEV1%pred, percentage-predicted FEV1; FVC, forced vital capacity; FVC%pred, percentage-predicted FVC; Normal, normal value; Patient, patient's value; RV, residual volume; TLC, total lung capacity; TLC%pred, percentage-predicted TLC; VA, alveolar volume.